Home
>
Stock Market
>
>
Aarti Drugs Ltd

Aarti Drugs Ltd share price and stock overview

Aarti Drugs Ltd (NSE: AARTIDRUGS, BSE: 524348) operates in the Pharmaceuticals - Indian - Bulk Drugs sector. The stock has an ISIN of INE767A01016 and a face value of Rs 10. As of 29 October 2026, it trades at Rs (450.20) with a market capitalisation of Rs 4086.16 crore. Figures are live and subject to change.

Aarti Drugs Ltd

Pharmaceuticals - Indian - Bulk Drugs

NSE BSE

450.20 2.30 (0.51%) upARrowC

As on: 29-Oct-2026 , 02:13 PM

Market Cap(₹Cr) 4086.16

Book Value(₹Cr) 153.9159417

BSE Code : 524348 NSE Symbol : AARTIDRUGS EPS(TTM) : 18.95 ISIN Demat : INE767A01016 P/E(TTM) : 23.63 Face Value(₹) : 10 Div & Yield % : 0.45

Today Market

Stock Performance

Today Market

Today's High

74,007.70

Todday's Low

73,181.90

Open at

73,268.47

Previous Close

73,246.03

Volumes

0.00

Avg Price

724.18

Historical Performance

News

27 Oct 26

Aarti Drugs to convene a board meeting November 3 to review financial results

Aarti Drugs Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve audited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing.

07 Oct 26

Aarti Drugs reported securities dematerialization processing confirmation from MUFG Intime India

Aarti Drugs Limited informed the BSE and National Stock Exchange that MUFG Intime India Private Limited, formerly Link Intime India Private Limited, confirmed the receipt and processing of securities for dematerialization during the quarter ended September 30, 2026, in accordance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

29 Sep 26

Aarti Drugs will halt trading ahead of financial results declaration in late September

Aarti Drugs Limited will close its trading window from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026, as per SEBI (Prohibition of Insider Trading) Regulations, 2015, the company said in a filing to the BSE Limited and National Stock Exchange of India Limited.

26 Sep 26

Aarti Drugs appoints Adhish Patil as Managing Director, effective October 1, 2026

Aarti Drugs Limited announced several changes to its management at its 41st Annual General Meeting on September 26, 2026.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
28-10-26	405.00	456.90	405.00	447.90	11572516	195571	5163672733.50	22698.85
27-10-26	381.00	404.80	380.85	402.25	324800	9653	128463062.85	22749.75
26-10-26	374.00	382.80	368.85	379.35	91644	6278	34520709.10	22753.20
23-10-26	380.25	386.35	370.30	374.90	193036	8721	72643911.70	22600.00
22-10-26	388.90	389.25	371.00	380.05	159060	8128	60254384.15	22687.65
21-10-26	396.00	398.30	385.00	388.60	93130	4074	36359536.70	22811.35
19-10-26	400.00	405.15	387.90	399.30	104210	5392	41440143.10	22888.95
16-10-26	396.45	399.45	392.50	396.35	69625	3807	27595952.85	23146.15
15-10-26	401.25	403.90	395.00	396.45	78406	4443	31238012.20	22997.35
14-10-26	410.05	410.25	399.90	400.60	103261	5235	41698298.45	22622.70

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

4086.16

PE Ratio

23.63

PB Ratio

2.91

Dividend Yield

0.45

ROE

12.74

ROCE

11.64

Book Value (₹)

153.9159417

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	8571669	9.39	8571669	7
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	38118254	41.76	38118254	28
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	2661305	2.92	2661305	6
Others	0	0.00	0	0

Sub Total

49351228

54.07

49351228

Total ShareHolding for Promoter & Group

49351228

54.07

49351228

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	16	0.00	16	1
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	2062790	2.26	2062790	68
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	70214	0.08	70214	1
Mutual Funds / UTI	9097000	9.97	9097000	4
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	178510	0.20	178510	6
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

11408530

12.50

11408530

Non Institution

Bodies Corporate	984294	1.08	984293	366
Clearing Members	29785	0.03	29785	21
Directors & their Relatives	4952436	5.43	4950611	7
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	813812	0.89	813812	2273
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	711676	0.78	711676	2966
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	5068529	5.55	5036529	74
Individuals holding nominal share capital up to Rs. 1 lakh	16705843	18.30	16182078	134073
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	1	0.00	1	1
Others	1001336	1.10	1001336	5

Sub Total

30510242

33.43

29952651

139828

Total Public Shareholding

41918772

45.93

41361181

139908

Total of Promoter & Public ShareHolding

91270000

100.00

90712409

139949

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

91270000

100.00

90712409

139949

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	2,565.31	2,387.03	2,528.58	2,716.05	2,488.65
OPM (%)	8.22	8.87	9.31	8.25	10.85
OP	210.90	211.77	235.53	224.18	269.96
Other Income	2.39	16.36	4.03	2.19	11.32
PBIDT	311.59	303.42	320.49	307.80	340.75
INTEREST	33.71	35.87	33.52	33.29	20.75
PBDT	277.87	267.55	286.98	274.51	320.00
PBT	210.90	211.77	235.53	224.18	269.96
EO	0.00	0.00	0.00	0.00	0.00
PBT after EO	210.90	211.77	235.53	224.18	269.96
TAXES	15.96	43.67	63.94	57.82	64.96
PAT	194.92	168.16	171.42	166.31	205.04
EPS	21.36	18.35	18.65	17.97	22.12
Raw Material	57.70	59.14	61.14	64.15	65.96
Power and Fuel	6.68	6.42	5.96	5.63	5.04
Employee Cost	5.04	4.70	4.05	3.39	3.32
Other Manufacturing Expenses	2.28	2.19	1.88	1.26	1.55
Selling and Administration Expenses	3.64	3.41	2.77	3.45	3.67
Miscellaneous Expenses	0.73	0.68	0.63	0.53	0.49
Revenue (Growth %)	7.47	-5.60	-6.90	9.14	15.49
PBIDT (Growth %)	2.69	-5.33	4.12	-9.67	-22.88
PAT (Growth %)	15.91	-1.90	3.07	-18.89	-26.88
PBIDT (Margin %)	12.15	12.71	12.67	11.33	13.69
PAT (Margin %)	7.60	7.04	6.78	6.12	8.24

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	91.27	91.27	91.94	92.60	92.60	93.20
Reserves Total	1313.52	1160.08	1083.27	1021.70	879.57	766.41
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1404.79	1251.35	1175.21	1114.30	972.17	859.61
Secured Loans	350.14	409.19	365.66	436.24	449.11	219.77
Unsecured Loans	70.83	106.38	109.06	99.24	70.25	115.96
Total Debt	420.97	515.57	474.72	535.48	519.36	335.73
Other Liabilities	3.54	3.60	2.91	3.15	17.42	29.39
Total Liabilities	1829.30	1770.52	1652.84	1652.93	1508.95	1224.73
APPLICATION OF FUNDS :
Gross Block	1623.74	1359.59	1276.97	1141.55	1112.47	1049.30
Less : Accumulated Depreciation	652.40	598.35	554.67	507.07	463.05	418.78
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	971.34	761.24	722.30	634.48	649.42	630.52
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	106.20	273.40	221.62	160.75	59.62	15.95
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	72.30	42.40	29.97	28.62	28.03	24.32
Current Assets, Loans & Advances
Inventories	405.35	407.23	441.77	477.73	488.46	390.38
Sundry Debtors	732.41	701.72	643.95	801.68	711.64	503.99
Cash and Bank Balance	4.70	4.57	3.82	2.68	2.21	3.81
Loans and Advances	70.30	67.02	91.48	67.45	70.88	61.96
Total Current Assets	1212.76	1180.55	1181.02	1349.53	1273.19	960.13
Less : Current Liabilities and Provisions
Current Liabilities	465.38	425.81	445.02	467.44	452.95	336.03
Provisions	8.46	3.20	4.03	6.76	2.59	1.28
Total Current Liabilities & Provisions	473.84	429.01	449.05	474.20	455.53	337.30
Net Current Assets	738.92	751.54	731.98	875.33	817.66	622.82
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.48	1.35	1.02	0.00	0.00	0.00
Deferred Tax Liability	79.94	74.60	70.76	68.37	70.04	74.97
Net Deferred Tax	-78.46	-73.25	-69.74	-68.37	-70.04	-74.97
Other Assets	19.01	15.20	16.71	22.11	24.26	6.09
Total Assets	1829.31	1770.52	1652.84	1652.92	1508.94	1224.73
Contingent Liabilities	331.00	267.22	242.23	191.39	178.21	151.02

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	84.11	-30.54	-148.81	-84.60	-126.27
Investing Activities	-125.36	-131.14	-187.09	-134.92	-127.58
Net Cash Flow	-1.35	0.03	1.20	0.56	0.29
Operating Activities	39.90	161.70	337.10	220.08	254.14

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarey Drugs & Ph...

109.00

(+0.88%)

Acutaas Chemical...

3,970.00

(+7.01%)

Anuh Pharma Ltd

79.75

(+0.18%)

Asston Pharmaceu...

Astonea Labs Ltd

Auro Laboratorie...

Bacil Pharma Ltd

Beta Drugs Ltd

1,863.90

(-5.71%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

CVG

Chandrakant V. Gogri

Chairman Emeritus

Executive

Functional Directors

PMP

Prakash M Patil

CMD & Executive Director

Exec.

HPS

Harit P Shah

E D & Wholetime Director

Dir.

UMP

Uday M Patil

WTD & Executive Director

Exec.

NJS

Narendra Jagannath Salvi

Non Executive Director

Exec.

Independent Directors

AVP

Ankit Vikram Paleja

Independent Non Exe. Director

Ind.

BNT

Bhaskar Narayan Thorat

Independent Non Exe. Director

Ind.

Neha Gada

Independent Non Exe. Director

Ind.

Hasmukh Dedhia

Independent Non Exe. Director

Ind.

SMJ

Sandeep Madhusudan Joshi

Independent Non Exe. Director

Ind.

SAE

Shri Ajit E. Venugopalan

Independent Non Exe. Director

Ind.

Other Officials

RCG

Rashesh C Gogri

ED / MD / Promoter

Board

HMS

Harshit M Savla

ED / Joint MD / Promoter

Board

RVD

Rushikesh V Deole

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Aarti Drugs Ltd? −

Aarti Drugs Ltd trades on NSE under AARTIDRUGS and on BSE under code 524348. The ISIN is INE767A01016 and the face value is Rs 10.

What is the share price of Aarti Drugs Ltd today? +

As of 29 October 2026, Aarti Drugs Ltd trades at Rs 450.20, a change of 2.30 (0.51%) on the day. Prices are live and subject to change.

What is the market capitalisation of Aarti Drugs Ltd? +

As of 29 October 2026, Aarti Drugs Ltd has a market cap of about Rs 4086.16 crore. This figure is live and moves with the share price.

Is Aarti Drugs Ltd profitable? +

In March 2026, Aarti Drugs Ltd reported a profit after tax of Rs 194.92 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Aarti Drugs Ltd? +

: As of 29 October 2026, the PE (TTM) for Aarti Drugs Ltd is 23.63 and the price-to-book ratio is 2.91. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Aarti Drugs Ltd pay a dividend? +

As of 29 October 2026, the dividend yield for Aarti Drugs Ltd is 0.45%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Aarti Drugs Ltd? +

As of the latest disclosed pattern, promoters hold 54.07% of Aarti Drugs Ltd. Public shareholding is 45.93%, including mutual funds at 9.97% and foreign institutional investors at 2.26%.

What were the latest annual financials of Aarti Drugs Ltd? +

In March 2026, Aarti Drugs Ltd reported net sales of Rs 2,565.31 crore, revenue growth of 7.47%, and earnings per share of Rs 21.36.